Lifecome BiochemistryLtd Yönetim

Yönetim kriter kontrolleri 2/4

Lifecome BiochemistryLtd CEO'su Tanping Lai, Dec2009 tarihinde atandı, in görev süresi 14.92 yıldır. şirketin hisselerinin 1% doğrudan sahiptir ve bu hisselerin değeri CN¥ 25.84M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 8.8 yıl ve 6.5 yıldır.

Anahtar bilgiler

Tanping Lai

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	14.9yrs
CEO sahipliği	1.0%
Yönetim ortalama görev süresi	8.8yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Prospects Need A Boost To Lift Shares

Oct 04

Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 26% Plummet

Apr 21

Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Mar 06

CEO

Tanping Lai (60 yo)

14.9yrs

Görev süresi

Mr. Tanping Lai is General Manager & Chairman of the Board of Lifecome Biochemistry Co.,Ltd. from December 2009 and is its Acting Secretary.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhongshou Bao	CFO, Financial Director & Accounting Supervisor	12.5yrs	CN¥228.30k	0.070% CN¥ 1.8m
Junhui Li	Deputy GM & Technical Director	7.5yrs	CN¥244.10k	0.081% CN¥ 2.1m
Jing Yang	Deputy GM & Director	3.7yrs	CN¥337.90k	Veri yok
Hui Huang	Deputy General Manager	8.8yrs	CN¥378.90k	0.13% CN¥ 3.4m
Tanping Lai	Chairman of the Board	14.9yrs	Veri yok	1% CN¥ 25.8m

8.8yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: 002868 'un yönetim ekibi deneyimli ve deneyimlidir ( 8.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Jing Yang	Deputy GM & Director	2.1yrs	CN¥337.90k	Veri yok
Tanping Lai	Chairman of the Board	14.9yrs	Veri yok	1% CN¥ 25.8m
Zhenwu Feng	Supervisory Board Chairman	18.5yrs	Veri yok	0.074% CN¥ 1.9m
Lijun Lou	Shareholder Representative Supervisor	12.5yrs	Veri yok	0.032% CN¥ 834.6k
Jiumin Lai	Non-Independent Director	3.7yrs	Veri yok	Veri yok
Hongming Hong	Non-Independent Director	3.7yrs	CN¥85.90k	Veri yok
Qing Tan	Independent Director	6.5yrs	CN¥85.90k	Veri yok
Xinren Zhang	Independent Director	6.5yrs	Veri yok	Veri yok
Xuebin Fan	Independent Director	6.5yrs	CN¥85.90k	Veri yok
Jun Meng	Employee Representative Supervisor	3.7yrs	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 002868 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Lifecome BiochemistryLtd Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Lifecome Biochemistry Co.,Ltd., Annual General Meeting, May 20, 2024

Lifecome Biochemistry Co.,Ltd., Annual General Meeting, Jun 29, 2023

High number of new directors

Recent updates

Third quarter 2024 earnings released: CN¥0.45 loss per share (vs CN¥0.26 loss in 3Q 2023)

Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Prospects Need A Boost To Lift Shares

Lifecome Biochemistry Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released: CN¥0.36 loss per share (vs CN¥0.22 loss in 2Q 2023)

Lifecome Biochemistry Co.,Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Lifecome Biochemistry Co.,Ltd., Annual General Meeting, May 20, 2024

Full year 2023 earnings released: CN¥1.44 loss per share (vs CN¥0.79 loss in FY 2022)

Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 26% Plummet

Lifecome Biochemistry Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

New minor risk - Share price stability

Lifecome Biochemistry Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 19, 2024

Third quarter 2023 earnings released: CN¥0.26 loss per share (vs CN¥0.20 loss in 3Q 2022)

Lifecome Biochemistry Co.,Ltd. to Report Q3, 2023 Results on Oct 30, 2023

Second quarter 2023 earnings released: CN¥0.22 loss per share (vs CN¥0.18 loss in 2Q 2022)

Lifecome Biochemistry Co.,Ltd., Annual General Meeting, Jun 29, 2023

Full year 2022 earnings released: CN¥0.79 loss per share (vs CN¥0.17 loss in FY 2021)

Third quarter 2022 earnings released

Second quarter 2022 earnings released: CN¥0.18 loss per share (vs CN¥0.02 profit in 2Q 2021)

Lifecome Biochemistry Co.,Ltd. Approves Not to Pay Cash Dividend for 2021

High number of new directors

Full year 2021 earnings released: CN¥0.17 loss per share (vs CN¥0.28 profit in FY 2020)

Second quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.14 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.085 in 1Q 2020)

Lifecome Biochemistry Co., Ltd. Proposes Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥0.28 (vs CN¥0.36 in FY 2019)

New 90-day low: CN¥11.40

Lifecome Biochemistry Co., Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day low: CN¥12.02

New 90-day low: CN¥13.05

Third quarter 2020 earnings released: EPS CN¥0.061

New 90-day low: CN¥13.35

New 90-day low: CN¥13.76

New 90-day high - CN¥16.02

First half earnings released

Lifecome Biochemistry Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş